• Tempest Therapeutics completes acquisition of CAR‑T assets from Factor Bioscience
Factor Bioscience - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

  • The Verge AI

    The Verge AI

    21 followers

  • TechCrunch AI

    TechCrunch AI

    19 followers

  • Crunchbase News AI

    Crunchbase News AI

    15 followers

  • TechRadar

    TechRadar

    15 followers

  • Hacker News

    Hacker News

    13 followers

See More →

Top Creators

  • Ryan Allis

    Ryan Allis

    215 followers

  • Elon Musk

    Elon Musk

    81 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    59 followers

  • Jack Dorsey

    Jack Dorsey

    40 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    217 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeFactor Bioscience
Factor Bioscience logo

Factor Bioscience

0 followers

About Factor Bioscience

Factor Bioscience engineers cells to develop advanced therapies, focusing on mRNA, gene editing, cell reprogramming, and nucleic acid delivery to create allogeneic cell therapies. The company emphasizes collaboration with strategic partners to accelerate development of transformational medicines and has a strong emphasis on regenerative and immuno-oncology applications, with operations based in Cambridge, Massachusetts and other sites. Their work centers on rewriting cellular programs to repair mutations, resist infections, and enhance cancer immunotherapies, supported by a patent portfolio and in-house manufacturing capabilities.

Recent News

No recent news for this company.

Recent Deals

Tempest Therapeutics Completes Acquisition of CAR‑T Assets From Factor Bioscience

March 30, 2026

Key Team Members

John Wells

Founder & CEO

Katie Zobeck, Ph.D.

Co-Founder & Chief Scientific Officer

James Flanigon

Co-Founder & COO

Barbara Novak, Ph.D.

Head of Software & Bioinformatics

Todd Giehran

Contractor & CSO

Key Facts

HQ Location

Cambridge, United States

Founded

2011

Employees

1 - 10

Status

Private

Website

https://factor.bio